Conduct larger scale field testing of PHA Camelina lines
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 19 Jan 2021
- Due
- 31 Dec 2021
- Delivered
- Q4 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Yield10 has selected two PHA Camelina lines for larger scale field testing in 2021, pending the issuance of permits in the U.S.”
What we found
Evidence strength A What the grades mean
The company confirmed in its 2022 10-K filing that it successfully carried out field tests of its PHA Camelina traits during 2021.
-
A Yield10 Bioscience, Inc. 10-K filed 2022-03-25
“We currently have two PHA biomaterial traits, C3014 and C3015, in our development pipeline and we carried out successful field tests in 2020 and 2021.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Conduct
- Deliverable
- larger scale field testing of PHA Camelina lines
- Where
- U.S.
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: pending the issuance of permits in the U.S.
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Yield10 Bioscience, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C121702-022153 · Corrections policy